Progression-free survival
Progression-Free Survival (PFS) is a term used in the field of oncology to denote the length of time during and after treatment that a patient lives with the disease but it does not get worse. In a clinical trial, measuring the PFS is one way to see how well a new treatment works.
Definition[edit | edit source]
Progression-Free Survival is defined as the time from randomization (or start of treatment) to the time of progression or death from any cause. It is used as a surrogate endpoint in clinical trials for cancer.
Importance in Clinical Trials[edit | edit source]
In clinical trials, PFS is often used as a primary endpoint for the approval of a new therapy. The advantage of using PFS as an endpoint is that it requires fewer patients and a shorter follow-up period than overall survival, allowing for quicker and less expensive trials.
Criticism[edit | edit source]
Critics argue that PFS does not always correlate with a real benefit for patients, such as improved survival or quality of life. They also point out that the assessment of progression can be subjective.
See Also[edit | edit source]
Progression-free survival Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD